EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Radio‐Activated Selenium‐Doped Janus Ag/Ag 2 Se x S y Nanoparticles for Precise Cancer NIR‐II Fluorescence Imaging and Radiosensitization Therapy

Kang Zhu, Zhanyuan Li, Jingjing Cao, Yixi Cao, Jimei Wang, Shiyu Wang, Ling Chen, Huiqin Zhou, Wei Huang, Hanxun Zou, Qunsheng Li, Jing Mu und 1 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202417828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Kang Zhu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, College of Chemistry, College of Chemical Engineering, Beijing University of Chemical Technolo…. Hauptthemen laut MEDLINE: Selenium, Silver, Radiation-Sensitizing Agents, Optical Imaging. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Beijing Outstanding Young Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of radiotherapy (RT) is often limited by insufficient tumor selectivity and suboptimal therapeutic responses. To overcome these problems, a new kind of selenium‐doped Ag/Ag 2 S Janus nanoparticles (Ag/Ag 2 Se x S y JNPs) is presented as radio‐responsive molecular probes for precise tumor imaging and enhanced radiosensitization. By adjusting the selenium precursor input, heterojunction nanoparticles with tunable doping ratios are synthesized, optimizing X‐ray absorption and energy storage properties. Upon X‐ray irradiation, the Ag/Ag 2 Se x S y JNPs interact with overexpressed hydrogen peroxide (H 2 O 2 ) in tumor cells, generating highly toxic hydroxyl radicals (·OH), which effectively induce tumor cell apoptosis. Additionally, Selenium incorporation improves electron–hole pair separation efficiency and enhances the photocurrent response, promoting increased electron transfer and ·OH generation, thus amplifying reactive oxygen species (ROS) production and enhancing radiosensitization. Furthermore, the fluorescence “OFF‐ON” mechanism, triggered by H 2 O 2 ‐induced etching of silver allows real‐time monitoring of H 2 O 2 levels via the second near‐infrared window (NIR‐II) fluorescence (FL) imaging “Turn On”, which delineates tumor boundaries for precise RT and reduce side effects to normal tissue. This dual‐functional platform not only enables real‐time tracking but also enhances therapeutic outcomes, offering a promising approach to precision cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeleniumSilverRadiation-Sensitizing AgentsOptical ImagingNeoplasmsMetal NanoparticlesSilver CompoundsNanoparticlesHumansAnimalsMiceCell Line, TumorHydrogen PeroxideReactive Oxygen SpeciesApoptosis

Stichwörter der Autor:innen

NIR‐II fluorescence imagingX‐raybioimagingjanus nanoparticleradiotherapy

Substanzen

SeleniumSilverRadiation-Sensitizing AgentsSilver CompoundsHydrogen PeroxideReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Resource Engineering, College of Chemistry, College of Chemical Engineering, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.
  • Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Department of Radiation Oncology, Jinan, 250117, P. R. China.
  • School of Materials Science and Engineering, University of Jinan, Jinan, 250022, P. R. China.
  • Fujian Provincial Key Laboratory of Ecology-Toxicological Effects & Control for Emerging Contaminants, Key Laboratory of Ecological Environment and Information Atlas, College of Environmental and Biological Engineering,…
  • Institute of Precision Medicine, Peking University Shenzhen Hospital, Shenzhen, 518036, P. R. China.

Förderung

  • National Natural Science Foundation of China
  • Shenzhen Medical Research Fund
  • Beijing Outstanding Young Scientist Program
  • National key research and development plan
  • Fundamental Research Funds for the Central Universities
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Zhu, K., Li, Z., Cao, J., Cao, Y., Wang, J., Wang, S., Chen, L., Zhou, H., Huang, W., Zou, H., Li, Q., Mu, J., & Song, J. (2025). Radio‐Activated Selenium‐Doped Janus Ag/Ag 2 Se x S y Nanoparticles for Precise Cancer NIR‐II Fluorescence Imaging and Radiosensitization Therapy. Advanced Science. https://doi.org/10.1002/advs.202417828

Vancouver

Zhu K, Li Z, Cao J, Cao Y, Wang J, Wang S, et al. Radio‐Activated Selenium‐Doped Janus Ag/Ag 2 Se x S y Nanoparticles for Precise Cancer NIR‐II Fluorescence Imaging and Radiosensitization Therapy. Advanced Science. 2025. doi:10.1002/advs.202417828

BibTeX
@article{Zhu2025,
  author = {Zhu, Kang and Li, Zhanyuan and Cao, Jingjing and Cao, Yixi and Wang, Jimei and Wang, Shiyu and Chen, Ling and Zhou, Huiqin and Huang, Wei and Zou, Hanxun and Li, Qunsheng and Mu, Jing and Song, Jibin},
  title = {Radio‐Activated Selenium‐Doped Janus Ag/Ag 2 Se x S y Nanoparticles for Precise Cancer NIR‐II Fluorescence Imaging and Radiosensitization Therapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202417828}
}
Kostenlos starten →